Neuroscience

Research Associate / Research Assistant in Neuroscience job with FLINDERS UNIVERSITY | 296177 – Times Higher Education

About Flinders

Our bold vision, captured in our Strategic Plan: making a Difference: The 2025 Agenda, is to be internationally recognised as a world leader in research, an innovator in contemporary education, and the source of Australias most enterprising graduates.

To realise this ambition, we recently made a significant organisation change to a six College structure with a professional staff and services alignment.

We recognise the key to our success is exceptional people and were seeking an outstanding individual to join the team of our transformed university.

Employment Type:

Fixed Term (Fixed Term)

Position Summary

Availability:Fixed-term until December 2024 | Full-Time

Compensation Grade:Research (Academic) Level AorHigher Education Officer Level 5

Salary Range:$78,340 - $94,938 p.a. (Level A)or$74,270 - $81,966 p.a. (HEO5)

Reporting To:Head of laboratory; Professor Damien Keating

The Research Associate will undertake research in the discipline of Human Physiology under the direction of the Chief Investigator, Professor Damien Keating. In working with Chief Investigator and research team, the incumbent will assist in leading the design and execution of the research project. Our research focuses on elucidating the role of the gut brain axis in regulating higher brain functions.

The incumbent may assist in leading students involved in the research Project, according to the Universitys policies, practices and standards.

Key Position Responsibilities

The Research Associate/Research Assistant in the Molecular and Cellular Physiology Laboratory in the Human Physiology discipline is accountable for:

Assisting in the planning, design and implementation of research projects, including:- Design, completion and analysis of laboratory experiments- Preparing research-related documentation- Liaising with research collaborators and key stakeholders

Key Position Capabilities

For more information regarding the position, or to have a confidential discussion, please contact: Professor Damien Keating

Note for Applicants: You will be required to specify in your application which career pathway you intend to apply for - Academic (Level A) or Professional (HEO5).

Information for Applicants:

You are required to provide a suitability statement of no more than three pages, addressing the key capabilities of the position as outlined above. In addition, you are required to upload your CV.

A valid National Police Certificate which is satisfactory to the University will also be required before the successful applicant can commence in this position.

We are seeking to increase the diversity to improve equal opportunity outcomes for employees, and therefore we encourage female applicants, people with a disability and/or from Aboriginal or Torres Strait Islanders descent to apply.

Please note, late applications and applications sent via agencies will not be accepted.

Applications Close 11:59 pm:

20 Jun 2022

Go here to see the original:
Research Associate / Research Assistant in Neuroscience job with FLINDERS UNIVERSITY | 296177 - Times Higher Education

Neuroscience

Shedding New Light on Human Brain Organization – Neuroscience News

Summary: A new map of the human brain reveals cells, receptors, and gene activity change along the same boundaries.

Source: Human Brain Project

Specific cellular, molecular and gene expression patterns in brain areas are linked to function, but their precise relationships remain largely unknown.

New findings by scientists at the Human Brain Project (HBP) shed light on these relationships and enable a more comprehensive understanding of human brain organisation.

The HBP researchers conducted a study that targeted three levels of cortical organisation: cytoarchitecture, neurotransmitter receptor architecture and neurotransmitter receptor gene expression.

The study elucidates principles of human brain organisation across the visual, auditory, somatosensory and motor functional systems, going beyond the simplified view of a mosaic of areas forming the neocortex.

The results were published in the journal Neuroimage.

To reveal the different properties of functional systems, and how brain areas within a functional system differ with respect to the processing hierarchy from primary to higher associative, the team analysed cytoarchitectonic and receptorarchitectonic data of the Julich Brain Atlas a three-dimensional multimodal atlas of the human brain and compared the data with transcriptomic data from the Allen Human Brain Atlas.

Bridging the gaps between different levels of brain organisation is one of the biggest challenges in neuroscience today. In the Julich Brain Atlas we can do it systematically. It integrates the data and is an invaluable tool, says Daniel Zachlod, first author of the study.

The researchers investigated the relationship of neurotransmitter receptor densities with their corresponding genes in 15 cytoarchitectonic areas of the visual, auditory, somatosensory and motor systems. They analysed differential gene expression within brain areas of each of those functional systems.

We found that the receptor architecture and gene expression patterns within a functional system change in a systematic way, in correspondence to increasing complexity of information processing, explains HBP Scientific Director Katrin Amunts, who is last author of the study.

The study demonstrates a method to unravel structure-function relationships by using the multilevel Julich-Brain Atlas to bridge the different scales of brain organisation.

Previous studies had already indicated the relevancy of receptor gene expression for the functional differentiation of the brain in rodents, but data on the human brain is much sparser and more fragmented.

The authors of the present study argue that it is mandatory to extend such studies to the human brain, in order to better understand the healthy brain, as well as pathogenesis of brain disorders with alterations in neurotransmitter systems.

Author: Helen MendesSource: Human Brain ProjectContact: Helen Mendes Human Brain ProjectImage: The image is in the public domain

Original Research: Open access.Combined analysis of cytoarchitectonic, molecular and transcriptomic patterns reveal differences in brain organization across human functional brain systems by Daniel Zachlod et al. NeuroImage

Abstract

Combined analysis of cytoarchitectonic, molecular and transcriptomic patterns reveal differences in brain organization across human functional brain systems

Brain areas show specific cellular, molecular, and gene expression patterns that are linked to function, but their precise relationships are largely unknown.

To unravel these structure-function relationships, a combined analysis of 53 neurotransmitterreceptor genes, receptor densities of six transmitter systems and cytoarchitectonic data of the auditory, somatosensory, visual, motor systems was conducted.

Besides covariation of areal gene expression with receptor density, the study reveals specific gene expression patterns in functional systems, which are most prominent for the inhibitory GABAAand excitatory glutamatergicNMDA receptors.

Furthermore, gene expression-receptor relationships changed in a systematic manner according to information flow from primary to higher associative areas.

The findings shed new light on the relationship of anatomical, functional, and molecular andtranscriptomicprinciples of cortical segregation towards a more comprehensive understanding of human brain organization.

View original post here:
Shedding New Light on Human Brain Organization - Neuroscience News

Neuroscience

What Oxytocin Can Tell Us About the Evolution of Human Prosociality – Neuroscience News

Summary: Study sheds new light on the genetics underlying possible social differences between modern humans, our ancestors, and other primate species.

Source: University of Barcelona

Modern humans are characterized by their prosociality, a broad term that encompasses intraspecies empathy, social tolerance, cooperation and altruism.

These facets of social cognition have been associated with variations in the oxytocin and vasotocin genes (OT and VT) and their receptors (OTR and VTR).

To shed light on the genetic basis of this behavior, scientists from the University of Barcelona (UB) and Rockefeller University carried out a new study comparing the available genomic sequences of these genes between modern humans, non-human primate species (e.g., chimpanzees, bonobos, and macaques) and, for the first time, archaic humans, using all the available genomes of Neanderthals and Denisovans.

In the study, published in the journalComprehensive Psychoneuroendocrinology, the researchers identified several sites in which modern humans differed from both archaic humans and non-human primates, and others where both modern and archaic humans differed from non-human primates.

We used an interdisciplinary approach to understand the evolution of hominid prosociality through the lens of the oxytocin and vasotocin receptors, where we combined evidence from modern and archaic genomics, population genetics, transcriptomics, and behavioral and neuroscientific studies, among other methods.

These results can shed light on the genetics underlying possible sociality differences identified between modern humans and archaic humans, as well as the similarities between the modern human and bonobo social behavior, said first author Constantina Theofanopoulou.

This research is part of her doctoral thesis carried out under the co-supervision of Cedric Boeckx, ICREA researcher at the Institute of Complex Systems at the UB (UBICS) and Erich D. Jarvis, professor at Rockefeller University.

Variants unique to modern humans in more than 70% of the population

Considering the evidence on modern human prosociality and on the involvement of the oxytocin and vasotocin genes in social behaviors, the researchers hypothesized that the evolution of these genes might elucidate the genetic basis of the evolution of hominin prosociality.

With this aim in mind, the study explored the differences between modern humans, archaic humans and non-human primates in polymorphic heterozygous sites in the human genome locations where at least two alternative sequences are found in a population.

Past studies that compared the entire modern human genome with the Neanderthal or the chimpanzee genomes have focused on changes that are fixed or nearly fixed in modern humans.

This has led to them identifying sites where, for example, all Neanderthals had Adenine (one of the four nucleotides that with guanine, cytosine and thymine form the DNA) and nearly all modern humans (say, 98%) have Guanine.

In this study, we searched for differences on locations where, by definition, not all modern humans share the same nucleotide, namely on polymorphic sites, where for example, 70% of the modern human population has Adenine and 30% Cytosine, adds Theofanopoulou.

The researchers identified five sites in the oxytocin and vasotocin receptors where modern humans are unique in one of their two (or more) variants compared to archaic humans and non-human primates, and which are at the same time found in more than 70% of the modern human population. Next, they conducted functional and frequency analyses to establish whether the variants are relevant.

They performed a range of analyses on the five sites and found that some of the variants are highly functional, indicating that they have an effect on the molecular function of the proteins activated by these genes.

The researchers also found that these sites are encountered in genome regions that are active in the brain, particularly in the cingulate gyrus, a brain region involved in social cognition-relevant pathways.

Moreover, all these sites have been associated in other studies with a plethora of social behaviors or social deficits, such as autism, attention deficit hyperactivity disorder (ADHD), aggression, and so on.

These findings may help to explain some of the social differences between modern humans and what we presume to know about the social behaviors of Neanderthals and Denisovans.

For example, they might be relevant to the smaller social groups attributed to Neanderthals and Denisovans or to the decreased modern human androgenization. They might also be relevant to a different social structure, i.e., Neanderthals have been linked to a polygynous social structure and a higher level of malemale competition than most contemporary modern human populations, says Constantina Theofanopoulou.

Variants present only in modern and archaic humans

The study also found two sites on the oxytocin receptor under a positive selection in modern and archaic humans: that is to say, modern and archaic humans showed a variant that was not present in any other non-human primate. This means that these sites are found in very high percentages in the modern human population (in this case, more than 85%).

These same sites have also been associated with a great many social behaviors or deficits, and one of them was predicted to be a highly functional site in their regulation analyses.

The sites that are unique in both us and archaic humans versus non-human primates can elucidate the genetic underpinnings of the progressive social tolerance needed for the intensive cultural transmission of technological innovations (e.g., fire use) in the evolution of humankind, as well as for the reduced aggression indicated by several markers in early hominid evolution, such as the reduction of male canine size and the accelerated demographic success, adds Theofanopoulou.

Convergent sites with bonobos

Lastly, the researchers found three sites where modern humans and bonobos, a primate species that shows convergence of prosocial behaviors with humans, have the same nucleotide.

The convergent sites in modern humans and bonobos could be insightful for understanding the posited similarities in prosociality, social tolerance and cooperation between us and bonobos, and the differences of both compared to chimpanzees.

For example, bonobos outperform chimpanzees on tasks relevant to social causality or theory of mind and are more attentive to the face and eyes, suggestive of higher empathic sensitivity, notes the researcher.

All the sites identified in this study have also been independently associated with disorders that include social deficits, such as autism spectrum disorders (ASD).

Understanding developmental disorders through evolutionary lenses can aid into us achieving what we call an evo-devo (evolutionary and developmental biology) understanding of these disorders. If indeed ontogeny recapitulates phylogeny, then deciphering our evolutionary trajectory may shed light to new genetic spots for clinical research that might, in turn, lead to earlier disorder diagnosis, highlights Constantina Theofanopoulou.

Future research in larger sample sizes

The next step in this research would be to test these results in larger sample sizes. This objective, as Theofanopoulou says, is easier to achieve in non-human primates such as chimpanzees and bonobos, but is more difficult in the case of Neanderthals or Denisovans, since obtaining access to more archaic genomes depends on archaeological finds, among other factors.

Another step is to widen the scope of the research and include more genes of the oxytocin pathway, or other genes highlighted in human evolution, such as dopamine, concludes the researcher.

Author: Rosa MartnezSource: University of BarcelonaContact: Rosa Martnez University of BarcelonaImage: The image is in the public domain

Original Research: Open access.Oxytocin and vasotocin receptor variation and the evolution of human prosociality by Constantina Theofanopoulou et al. Comprehensive Psychoneuroendocrinology

Abstract

Oxytocin and vasotocin receptor variation and the evolution of human prosociality

Modern human lifestyle strongly depends on complex social traits like empathy, tolerance and cooperation. These diverse facets ofsocial cognitionhave been associated with variation in theoxytocin receptor(OTR) and its sister genes, the vasotocin/vasopressin receptors (VTR1A/AVPR1AandAVPR1B/VTR1B).

Here, we compared the available genomic sequences of these receptors between modern humans, archaic humans, and 12 non-human primate species, and identified sites that show heterozygous variation in modern humans and archaic humans distinct from variation in other primates, and for which we could find association studies with clinical implications.

On these sites, we performed a range of analyses (variant clustering,pathogenicityprediction, regulation,linkage disequilibriumfrequency), and reviewed the literature on selection data in different modern-human populations.

We found five sites with modern human specific variation, where the modern human allele is the major allele in the global population (OTR: rs1042778, rs237885, rs6770632;VTR1A: rs10877969;VTR1B: rs33985287). Among them, variation in theOTR-rs6770632 site was predicted to be the most functional.

Two alleles (OTR: rs59190448 and rs237888) present only in modern humans and archaic humans were putatively under positive selection in modern humans, with rs237888 predicted to be a highly functional site.

Three sites showedconvergent evolutionbetween modern humans and bonobos (OTR: rs2228485 and rs237897;VTR1A: rs1042615), withOTR-rs2228485 ranking highly in terms of functionality and reported to be under balancing selection in modern humans (Schaschl, 2015) [1].

Our findings have implications for understanding hominid prosociality, as well as the similarities between modern human and bonobo social behavior.

More here:
What Oxytocin Can Tell Us About the Evolution of Human Prosociality - Neuroscience News

Neuroscience

Investigating Links Between Facial Recognition and Alzheimer’s Disease – Neuroscience News

Summary: Study evaluates whether problems in facial processing and recognition in Alzheimers disease are a result of memory impairment or visual processing deficits.

Source: KTU

In recent years Alzheimers disease has been on the rise throughout the world and is rarely diagnosed at an early stage when it can still be effectively controlled.

Using artificial intelligence, KTU researchers conducted a study to identify whether human-computer interfaces could be adapted for people with memory impairments to recognize a visible object in front of them.

Rytis Maskelinas, a researcher at the Department of Multimedia Engineering at Kaunas University of Technology (KTU), considers that the classification of information visible on the face is a daily human function: While communicating, the face tells us the context of the conversation, especially from an emotional point of view, but can we identify visual stimuli based on brain signals?

The visual processing of the human face is complex. Information such as a persons identity or emotional state can be perceived by us, analysing the faces. The aim of the study was to analyse a persons ability to process contextual information from the face and detect how a person responds to it.

Face can indicate the first symptoms of the disease

According to Maskelinas, many studies demonstrate that brain diseases can potentially be analysed by examining facial muscle and eye movements since degenerative brain disorders affect not only memory and cognitive functions, but also the cranial nervous system associated with the above facial (especially eye) movements.

Dovil Komolovait, a graduate of KTU Faculty of Mathematics and Natural Sciences, who co-authored the study, shared that the research has clarified whether a patient with Alzheimers disease visually processes visible faces in the brain in the same way as individuals without the disease.

The study uses data from an electroencephalograph, which measures the electrical impulses in the brain, says Komolovait, who is currently studying for a masters degree in Artificial Intelligence program at the Faculty of Informatics.

In this study, the experiment was performed on two groups of individuals: healthy and affected by Alzheimers.

The brain signals of a person with Alzheimers are typically significantly noisier than in a healthy person, says Komolovait, emphasizing that this correlates with a reason which makes it more difficult for a person to focus and be attentive when experiencing the symptoms of Alzheimers.

Photos of peoples faces were shown during the study

The study selected a group of older people made up of women over 60 years of age: Older age is one of the main risk factors for dementia, and since the effects of gender were noticed in brain waves, the study is more accurate when only one gender group is chosen.

During the study, each participant performed experiments lasting up to an hour, during which the photos of human faces are shown.

According to the researcher, these photos were selected according to several criteria: in the analysis of the influence of emotions, neutral and fearful faces are shown, while analysing the familiarity factor, known and randomly chosen people are indicated to the participants of the study.

In order to understand whether a person sees and understands a face correctly, the participants of the study were asked to press a button after each stimulus to indicate whether the face shown is inverted or correct.

Even at this stage, an Alzheimers patient makes mistakes, so it is important to determine whether the impairment of the object is due to memory or vision processes, says the researcher.

Inspired by real-life interactions with Alzheimers patients

Maskelinas reveals that his work with Alzheimers disease started with his collaboration with the Huntingtons Disease Association, which opened his eyes to what these many neurodegenerative diseases really look like.

The researcher also had direct contact with Alzheimers patients: I saw that the diagnosis is usually confirmed too late when the brain is already irreversibly damaged. Although there is no effective cure for this disease, the process can be paused and sustained by gaining some healthy years of life.

Today, we can see how human-computer interaction is adapted to alleviate the life of people with physical disabilities. Controlling a robotic hand by thought or a paralysed person writing a text by imagining letters is not a new concept. Still, trying to understand the human brain is probably one of the most challenging tasks remaining today.

In this study, the researchers worked with the data from the standard electroencephalograph equipment, however, Maskelinas emphasises that in order to create a practical tool, it would be better to use data gathered from invasive microelectrodes, which can more accurately measure the activity of neurons. This would increase the quality of the AI model substantially.

Of course, in addition to the technical requirements, there should be a community environment focused on making life easier for people with Alzheimers disease. Still, in my personal opinion, after five years, I think we will still see technologies focused on improving physical function, and the focus on people affected by brain diseases in this field will only come later, says Maskelinas.

According to the masters student Komolovait, a clinical examination with the help of colleagues in the field of medicine is necessary, therefore this stage of the process would take a lot of time: If we want to use this test as a medical tool, a certification process is also needed.

Author: Aldona TuurSource: KTUContact: Aldona Tuur KTUImage: The image is in the public domain

Original Research: The findings will be presented in Life

Excerpt from:
Investigating Links Between Facial Recognition and Alzheimer's Disease - Neuroscience News

Biochemistry

Department of Biochemistry | College of Natural & Agricultural Sciences

How do basic principles foster life? We believe the answer can be found at the intersection of chemistry, physics, and biologyin other words, biochemistry. The Department of Biochemistry at UC Riverside is dedicated to the elucidation of these principles. With our world-class faculty, enthusiastic graduate students, and promising undergraduates, we aim to sharpen minds and foster curiosity that lends itself to high-quality research. Our department, and the rest of UC Riverside, is in a current period of growth, and we would love for you to be a part of this positive change.

Biochemistry Faculty at UC Riverside specialize in a variety of subfields of biochemistry, including Structural Biology, Enzymology, Plant Biochemistry, and Biomedical Research. A strong dedication to interdepartmental collaboration and cooperation among faculty allows our graduate students the flexibility to pursue their interests. With an extensive group of cooperative faculty across the College of Natural and Agricultural Sciences, Bourns School of Engineering, and the UCR School of Medicine, it is our hope that our students can work at the intersection of various fields to pursue cutting-edge research in their search for answers to the most fundamental principles of biology.

Our program hosts a large number of undergraduate students every year, who can choose a biochemistry major focused in chemistry, biology, or medical sciences. To encourage involvement in the field from students of all walks of life, UC Riverside offers various competitive research programs aimed toward minority and economically disadvantaged students. In addition, a high percentage of our undergraduates find that they qualify for student aid covering up to their entire tuitionbecause we believe that money should not bar anyone from seeking a higher education.

I hope that this website will serve as a helpful resource for potential or current students, staff, visiting scholars and donors.

Visit link:
Department of Biochemistry | College of Natural & Agricultural Sciences

Biochemistry

Biochemistry – McGill University

Welcome to Biochemistry

How do cells work? How do dysfunctional molecular interactions result in diseases? And how could we design molecules to cure those diseases? Biochemistry is the science that explains life at a molecular level and finds solutions to complex health disorders. Whether you are looking for a career as laboratory scientist, clinical biochemist, forensic scientist, geneticist, precision medicine consultant, medical liaison manager, or if you simply want to become a top notch researcher recognized worldwide, Biochemistry provides the solid core program and opportunities you were looking for.

.

Read more from the original source:
Biochemistry - McGill University

Biochemistry

Masters in Biochemistry and Molecular Biology | Georgetown University

The Master of Science in Biochemistry & Molecular Biology at Georgetown University is a basic science program that infuses core concepts of biochemistry and molecular biology as applied to biomedical sciences and biotechnology, providing students with a rigorous and challenging curriculum. Graduates from the program excel in various career paths with government agencies, academic institutions, research laboratories, and biotechnology companies. Alumni have also continued their education by pursuing doctoral, medical, and law degrees, using the skills and training at Georgetown University to propel their future academic and research careers.

Core concepts and skills are taught through required core courses, advanced electives, special topics courses, and a 4 credit internship. At least 30 graduate credits with a cumulative GPA of 3.0 or greater are required for the M.S. degree. Our courses expose students to advanced methods in biochemistry, molecular biology, and cell biology, laboratory research, and literature-based research and include a significant number of hands-on lab-based courses that develop research expertise.

Our program offers a well-organized, intensive capstone internship program that culminates in students presenting their research at tri-annual poster presentation sessions. The internships are done with research mentors in various GUMC laboratories on-campus, or off-campus in government agencies such as NIH and FDA or biotechnology companies.

Read more:
Masters in Biochemistry and Molecular Biology | Georgetown University

Biochemistry

ACS announces 2022 awards – ASBMB Today

In late March, the American Chemical Society announced its awards for 2022. Among the honorees were American Society for Biochemistry and Molecular Biology members Karen Allen, Benjamin Cravatt, Kimberly Jackson and Carlito Lebrilla.

Karen Allen

Karen Allen, a professor and chair of the chemistry department at Boston University, won the 2022 Abeles and Jencks Award for the Chemistry of Biological Processes. Allen's lab studies the structure, function and mechanisms of phosphatases, phosphoglycosyltransferases and decarboxylases, working to understand both reaction mechanisms and enzyme evolution. Allen is a co-organizer of the 2023 ASBMB Annual Meeting. She is the inaugural recipient of this award, which was named for the late enzymologists William Jencks and Robert Abeles, who taught and studied mechanistic enzymology at Brandeis University. Given by the ACS division of biological chemistry, the award celebrates "outstanding contributions to the understanding of the chemistry of biological processes."

Benjamin Cravatt

Benjamin Cravatt, a professor of chemistry and chair of chemical biology at Scripps Research, received the Alfred Bader Award for outstanding contributions in bioinorganic or bioorganic chemistry. Cravatt's lab developed a technique to use chemical probes that bind to and tag enzymes active sites, enabling researchers to read out enzyme activity at proteome scale. They have used the technique to study endocannabinoid signaling, cancer and neurological disorders. Researchers in the lab have also extended their methods to globally map small moleculeprotein interactions and discover chemical probes for historically undruggable proteins. Cravatt was also one of three recipients of the 2022 Wolf Prize in Chemistry, and he won the ASBMBMerck Award in 2014. The late Alfred Bader, a Canadian chemist, businessman and philanthropist, and his family established this award in 1986.

Kimberly Jackson

Kimberly Jackson, a professor and chair of the department of chemistry and biochemistry at Spelman College, received the ACS award for Encouraging Disadvantaged Students into Careers in the Chemical Sciences. Jackson is director of the food studies program at Spelman, a historically black college. Her lab studies potential therapeutic molecules for advanced prostate cancer, and many of the undergraduates who have trained with her later earned Ph.D.s or medical degrees. The award includes a prize of $10,000, which Jackson directed to an Atlanta-based nonprofit called PinkSTEM that aims to empower girls to succeed in science, technology, engineering and mathematics.

Carlito Lebrilla

Carlito Lebrilla, a distinguished professor and former chair of the chemistry department at the University of California, Davis, received the Frank H. Field and Joe L. Franklin Award for Outstanding Achievement in Mass Spectrometry. Known for his glycoproteomics work, Lebrilla studies disease biomarkers in cancer and Alzheimers disease, along with bioactive compounds breast milk and how milk glycoproteins affect infant microbiomes. Lebrilla is a member of the editorial advisory board of Molecular & Cellular Proteomics. This ACS award, sponsored by the Waters Corporation, is named for two noted mass spectrometrists; Field worked in developing chemical ionization, and Franklin studied the chemistry of ion molecules.

Go here to read the rest:
ACS announces 2022 awards - ASBMB Today

Biochemistry

Companion Animal Diagnostics Market: Competitive Landscape Analysis with Forecast by 2027 – BioSpace

Wilmington, Delaware, United States: Companion animals are used for extrovert display, psychological support, and amusement support. Companion animals include dogs and cats. Companion animal diagnostics is an integral part of management as well as prevention of outbreaks of diseases among companion animals.

Read Report Overview - https://www.transparencymarketresearch.com/companion-animal-diagnostics-market.html

Companion animal diagnostics include clinical biochemistry products, immunodiagnostics, hematology, and others. These are used in the treatment of diseases associated with the immunological system, digestive system, reproductive system, respiratory system, and urinary system of companion animals.

Increase in obesity and various diseases in companion animals, globally, has fueled the need for new diagnostic options. In developed countries such as the U.S., governments strongly emphasize on pet insurance. Clinical biochemistry technology is widely utilized in the diagnosis of veterinary diseases with the help of blood and urine analysis. Companion animal diagnostic products are mostly used in clinical pathology due to increasing demand for diagnostic products in pathology labs and rising number of pathology tests performed on pets. In terms of companion animals, dog are a highly popular companion animals. In terms of competition, IDEXX Laboratories, Inc. and Zoetis, Inc. are major manufacturers of companion animal diagnostic products.

Increase in the demand for advanced products for veterinary disease diagnosis boosts the global companion animal diagnostics market.

Request a Report Brochure to Gain Comprehensive Insights at https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=66719

Companion Animal Diagnostics Market: Overview

Increase in companion animal ownership is a major trend being witnessed in the animal healthcare market. Spending capacity on companion animals is also on the rise.

According to the National Pet Owners Survey conducted by the American Pet Products Association (APPA) in 2018, around 68% of households in the U.S own a companion animal or pet.

According to a report published by the Federal Trade Commission (FTC), the U.S. government spent around US$ 72.5 Bn on its pet industry in 2018, which includes food, veterinary care, prescription and OTC medications, and other pet services and products.

Pet obesity is a major issue in the U.S. According to a report by the Association for Pet Obesity Prevention (APOP), in 2018, obesity affected around 55.8% of dogs and 59.5% of cats in the U.S.

Increased longevity of companion animals due to improvements in diagnostics, greater emphasis on wellness and prevention by veterinarians as well as owners, and better nutrition have expanded the use of companion animal diagnostics.

Due to all these factors, the global companion animal diagnostics market is set to expand at a high CAGR of ~9%, to be valued at ~US$ 5 Bn by the year 2027.

Get COVID-19 Analysis on Companion Animal Diagnostics Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=66719

Global Companion Animal Diagnostics Market: Key Segments

In terms of technology, clinical biochemistry is the leading segment in the global companion animal diagnostics market. This is due to major focus of manufacturers on launching new diagnostic products such as chemistry analyzers and glucose monitors. Additionally, extensive application of this technology and increase in the preference for point of care glucose monitoring devices is likely to fuel the segment in the global companion animal diagnostics market.

Clinical pathology is projected to be a highly attractive segment in the global companion animal diagnostics market during the forecast period. Clinical pathology is highly preferred for diagnosis over various companion animal diagnoses, and an increase in the prevalence of various chronic diseases associated with companion animals has led to an increase in the number of diagnosis tests. These factors boost the clinical pathology segment in the global companion animal diagnostics market.

Dogs are extremely popular companion animals all around the world as compared to any other animal. Increasing dog population and high incidence rate of obesity in dogs are projected to boost the segment in the global companion animal diagnostics market during the forecast period. Moreover, increasing pet ownership across the globe is also a major factor driving the segment in the overall companion animal diagnostics market.

Make an Enquiry before Buying - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=66719

Veterinary Reference Laboratories is a highly preferred end user in the global companion animal diagnostics market. Increase in the number of veterinary reference laboratories across the globe and availability of new diagnostic products in veterinary reference laboratories are expected to propel the retail pharmacies segment in the global companion animal diagnostics market.

Global Companion Animal Diagnostics Market: Major Players

Leading players analyzed in the report on the global companion animal diagnostics market include

More Trending Reports by Transparency Market Research:

Biochemistry Analyzers Market: Widespread advancements in the medical field have primarily been responsible for driving the global biochemistry analyzers market.

Veterinary Biochemistry Analyzers Market: Increasing incidences of disease outbreak in animals and technological advancements are expected to drive the veterinary biochemistry analyzers market.

Companion Diagnostics Market: The global companion diagnostics market is expected to witness tremendous growth opportunities due to rising incidences of oncology and chronic disorders across the globe.

Companion Animal Drugs Market: Rising number of companion pet adoption centers globally where companion animals need to be kept safe is increasing the demand for companion animal drugs to keep them healthy and safe.

Molecular Diagnostics Market: Rise in demand for personalized health care, and surge in awareness about molecular diagnostics are the key factors projected to drive the global molecular diagnostics market during the forecast period.

About Us

Transparency Market Research is a global market intelligence company providing market research reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact Us

Rohit Bhisey

Transparency Market Research Inc.

CORPORATE HEADQUARTER DOWNTOWN,

1000 N. West Street,

Suite 1200, Wilmington, Delaware 19801 USA

Tel: +1-518-618-1030

USA Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com/

Continued here:
Companion Animal Diagnostics Market: Competitive Landscape Analysis with Forecast by 2027 - BioSpace

Biochemistry

Senior Lecturer or Associate Professor in Biochemistry and Pharmacology job with UNIVERSITY OF MELBOURNE | 295930 – Times Higher Education

Location: ParkvilleRole type: Full time /ContinuingFaculty: Faculty of Medicine, Dentistry and Health SciencesDepartment/School:Department of Biochemistry and PharmacologySalary: Level C ($135, 032 - $155,698) OR Level D ($162,590 - $179,123) p.a. plus 17% super

Founded in 1853, the University of Melbourne is Australias #1 university and is consistently ranked amongst the leading universities in the world. We are proud of our people, our commitment to research and teaching excellence, and our global engagement.

About theDepartment of Biochemistry and Pharmacology

The Department of Biochemistry and Pharmacology is committed to developing the careers and wellbeing of our students and staff, fostering a culture that supports us all to do our best work. We are guided by our values in our pursuit of excellence.The Department of Biochemistry and Pharmacology has critical mass, interdisciplinary teaching and a remarkable breadth and depth in research expertise that underpin our key themes of molecular understanding of biology and disease, translational research, drug discovery and development. Our researchers are strongly committed to high-impact discovery research and in translating breakthroughs to societal outcomes when the opportunity arises.

The Department of Biochemistry and Pharmacology is strongly committed to supporting diversity and the representation of women. In line with the special measure H103/2014 provided for under section 12 of the Equal Opportunity Act 2010 (VIC), the Department of Biochemistry and Pharmacology strongly encourages applications from suitably qualified female candidates. We intend that at least one of the two appointees will be a female.

About the Role

We have two positions available as a Senior Lecturer or Associate Professor, who will develop and maintain a high-level research program in a field of pharmacology that is complementary to existing areas of research strength in the Department. You will be encouraged to contribute to interdisciplinary research within the School of Biomedical Science and Faculty of Medicine, Dentistry and Health Sciences and the wider academic community. You will also join a successful team in delivering and supporting teaching and learning in pharmacology and therapeutics within the Department and the broader School of Biomedical Sciences.

In a typical week at work, you may:

About You

You are a confident communicatorwith a demonstratable proactive reflective teaching practice. Your highly-developed interpersonal skills allow you to work collaboratively with internal and external colleagues, and you are passionate about mentoring and guiding junior research staff in their academic trajectory.

Ideally, you will further have:

Benefits of Working with Us

In addition to having the opportunity to grow and be challenged, and to be part of a vibrant campus life, our people enjoy a range of rewarding benefits:

To find out more, please visithttps://about.unimelb.edu.au/careers/staff-benefits.

Be Yourself

At UoM, we value the unique backgrounds, experiences and contributions that each person brings to our community, and we encourage and celebrate diversity. Indigenous Australians, those identifying as LGBTQIA+, females, people of all ages, with disabilities or culturally diverse backgrounds are encouraged to apply for our roles. Our aim is to create a workforce that reflects the community in which we live.

Join Us!

If you feel this role is right for you, please submit your application including a brief cover letter, your resume and your responses against the selection criteria^ (found in the Position Description) for the role.

^For information to help you with compiling short statements to answer the selection criteria and competencies, please go tohttp://about.unimelb.edu.au/careers/selection-criteria

Should you require any reasonable adjustments with the recruitment process, please contact the Talent Acquisition team athr-talent@unimelb.edu.au.

Due to the impacts of COVID-19, we are currently prioritising applications with current valid working rights in Australia and candidates who are not affected by travel restrictions. Please see the latest updates to Australia's immigration and border arrangements: https://covid19.homeaffairs.gov.au/

The University of Melbourne is required to comply with applicable health guidance and directions issued from the Victoria Health Minister. The University of Melbourne requires all University of Melbourne employees to be fully vaccinated against COVID-19, unless an exemption order applies. All applicants therefore must meet this requirement when submitting an application.

Position description:Senior Lecturer, Associate Professor PD.docx

Applications close:30 JUNE 2022 11:55 PMAUS Eastern Standard Time

Follow this link:
Senior Lecturer or Associate Professor in Biochemistry and Pharmacology job with UNIVERSITY OF MELBOURNE | 295930 - Times Higher Education